CNK
CNK
US17243V1026
Cinemark Holdings Inc Cinemark
Loading chart...
Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 45/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Largely moves in line with the broader market.

Beta (Market Relation)
1.03x
Above average
Volatility (5Y p.a.)
42.5% p.a.
5-Year Horizon
Max Drawdown (5Y)
-62.2%
5-Year Horizon
Sharpe Ratio
0.22
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

High Volatility
Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — +42.9%
3 Years 35.9% -39.1% 0.61 +24.5%
5 Years 42.5% -62.2% 0.22 +11.7%
10 Years 56.2% -85.2% -0.06 -0.8%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Critical leverage: Debt-to-Equity is at 588%.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (42.5% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -85.2% in the extended horizon.
ende